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Abstract 
Ethnopharmacological relevance: The aim of this study was to identify and 
document medicinal plants used to manage High Blood Pressure and Type 2 
Diabetes Mellitus in Bitterfontein, Western Cape Province, South Africa. 
Methods: One hundred and twelve (112) respondents were interviewed 
between August 2014 and September 2015 through semi-structured surveys to 
gather data on the percentage of people who had been diagnosed with High 
Blood Pressure and/or Type 2 Diabetes Mellitus and to determine the frequency 
of medicinal plant and allopathic medicine use. Twelve (12) key respondents 
were subsequently selected, using a non-probability snowball sampling method. 
They were interviewed in-depth concerning their plant practices and assisted 
with plant collection. 
Results: Twenty-four plant (24) species belonging to 15 families were identiﬁed 
for the management of High Blood Pressure and Type 2 Diabetes Mellitus. The 
most frequently reported families were Asteraceae (20.8%), Lamiaceae (16.67%), 
Crassulaceae (8.33%) and Aizoaceae (8.33%). The remaining (45.54%) were evenly 
split over eleven families- Fabaceae, Amaryllidaceae, Anacardiaceae, Capparaceae, 
Geraniaceae, Apiaceae, Convolvulaceae, Apocynaceae, Rutaceae, Asphodelaceae 
and Thymelaeaceae. The most commonly used plant species overall was Lessertia 
frutescens (96.55%). The most frequently used plant parts included leaves (57.63%) 
roots/bulbs (15.25%) and stems (11.86%), mostly prepared as infusions or 
decoctions for oral administration. 
Conclusions:  Medicinal plants are widely used by High Blood Pressure and Type 
2 Diabetes Mellitus suﬀerers. They employ diverse plant species to manage both 
conditions. In addition, some suﬀerers often use prescribed allopathic 
medication, as well as medicinal plants, but at diﬀerent intervals. Despite high 
usage the plants identiﬁed are not currently threatened (Red Data list status: 
least concern). 
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1. Introduction 
High Blood Pressure (HBP) and Type 2 Diabetes Mellitus (T2DM) are growing 
concerns worldwide. The rate of new cases and number of deaths caused by these 
two non-communicable diseases are a public health concern: alongside infectious 
diseases such as human immuno-deﬁciency virus (HIV) and tuberculosis (TB) 
(Cheung and Chao, 2012). According to the World health Statistics Report, one in 
three adults worldwide has HBP and one in ten has T2DM (World Health 
Organisation (2003, 2012)). There is substantial overlap between the two 
conditions in aetiology and disease mechanisms. Many of those aﬀected by T2DM 
also have, or go on to develop, HBP - a condition known as Diabetic Hypertensive 
(Balogun and Salako, 2011). The latter is a common condition in which the ﬂow of 
blood through the arteries occurs at pressures higher than normal. In its chronic 
state it is called Hypertension, i.e. when the blood pressure is higher than 140 
over 90 mmHg (Carretero and Oparil, 2000). South Africans over the age of 50 are 
especially at risk and currently have one of the highest occurrences of HBP in the 
world (Lloyd-Sherlock et al., 2014a). 
 
T2DM is deﬁned as a random blood glucose level (RGB) above P11.1 mmol/L, or 
RBG < 11.1 mmol/L (Bailey et al., 2016). T2DM is a chronic condition that aﬀects the 
way in which the body metabolizes sugar (glucose). The prevalence of T2DM is 
escalating worldwide (Kadima and Tumbo, 2013). In South Africa, approximately 
6% of the population suﬀers from T2DM (Bertram et al., 2014). According to the 
World Health Organisation's (WHO) (2016), this condition is the ﬁfth leading 
cause of death in South Africa. In the Western Cape Province, however, little 
information is available on the occurrence of T2DM. In prevalence surveys 
conducted in the Province, the statistics of T2DM ﬂuctuates from rural to urban 
areas and among diﬀerent population groups (Erasmus et al., 2012; Hughes et 
al., 2013; Health24, 2014;  Bailey  et al., 2016).  The prevalence of  T2DM is 
thought to be especially high among the coloured1 population (Erasmus et al., 
2012). This was the case in our study site, Bitterfontein. T2DM is also one of the 
biggest causes of natural death in the Western Cape (Bothma, 2014). HBP and 
T2DM are risk factors for an array of associated conditions such as cardiovascular 
disease, renal, neurovascular and retinal complications ((Balogun and Salako, 2011; 
Bertram et al., 2014). Given that there is a high correlation between HBP and 
T2DM, it is important to consider their co-occurrence, since they are pre-eminent 
in relation to morbidity and mortality. 
 
It is not clear from available literature how HBP and T2DM are managed in semi-
rural areas in the Western Cape where access to health care facilities, diagnosis 
and treatment may not be optimal (Health24, 2014). Little is known about the use 
of traditional herbal medicine (THM) to manage the above conditions and 
ethnobotanical studies do not always compare their ﬁndings with scientiﬁc studies 
that investigate the phytochemical eﬀects of THM. The use of THM in 
combination with allopathic medicine has also not been studied extensively. At the 
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same time, there has been increased concern about the cost and availability of 
pharmaceuticals, especially in rural areas. Prescribed medicines used for HBP and 
T2DM can produce side eﬀects such as headaches, nausea, vomiting, stomach pain, 
constipation, diarrhoea, weakness and fatigue. People often turn to THM to combat 
such symptoms and to manage their health, contributing to a growing tendency to 
consider THM that is known to promote good health, with minimal side eﬀects. This 
trend has led academic researchers, as well as the pharmaceutical industry, to 
consider THM as a potential source of new, safe and aﬀordable alternatives (Day, 
1998). THM, on the whole, are also believed to be relatively safe and harmonious 
with biological systems (Atal, 1983; Erasto, 2003). The practice of using nature as 
a source of medicine dates back in history and  various current medicines were 
originally derived from plants. As many herbal remedies have not been clinically 
tested, they are classiﬁed as complementary and alternative medicines and are 
considered to be generally aﬀordable and accessible. In South Africa a big 
informal market in THM exists (Street and Prinsloo, 2013). 
 
South Africa has a pluralistic health care system (Levine, 2012; Wreford et al., 
2006) and the usage of what is referred to as “traditional” medicines is often 
reported to be as high as 80%, although the frequency of use ﬂuctuates from one 
province to another and between rural and urban areas (Dold and Cocks, 2002; 
Nxumalo et al., 2011; Davids et al., 2014; Hughes et al., 2013). In the Western 
Cape, and especially in the Matzikama district, knowledge and usage of 
medicinal plants is often associated with the knowledge of elderly people 
(Davids, 2012), bossiesdokters (bush doctors/herbalists) (Cohen, 2009, 2013) 
and Rastafari bush doctors (Nortje, 2011; Philander, 2011; Philander et al., 
2014) and it is often intermingled with a range of knowledge heritages. The most 
prevalent in Matzikama is frequently termed Khoisan medicine (Low, 2007) or 
“Cape herbal medicine” (van wyk, 2008). The latter nomenclature intimates the 
intermixing of Khoisan ancestral healing knowledge and practices concerning 
medicinal plants with historical “Cape Dutch” inﬂuences in the Western Cape. 
Locally sourced medicinal plants fall under the rubric of “traditional” medicine in 
South Africa. Although the reality of pluralistic healing systems is accepted, 
notions of “traditional” medicine are nonetheless fraught with epistemological 
dilemmas (Ellen and Harris, 2000; Gibson, 2011). South African discourses on 
traditional medicine tend to draw on “traditional” knowledge/s in 
contradistinction to “Western” or “scientiﬁc” knowledge. HBP and/or T2DM 
suﬀerers, however, are often informed by both in their health care choices. This 
paper draws on the aforementioned debates to deﬁne THM as local knowledge, 
principally orally transmitted, which is common practice in the everyday life of 
users. THM knowledge is empirical and its display is somewhat repetitive but it is 
also transformative, it is produced and reproduced, and can be lost. The 
knowledge is dispersed, practical, and broadly holistic (Ibid: 5). For the purpose of 
this study and to avoid confusion, traditional herbal medicine utilised in the 
Matzikama district will hereafter be referred to as THM. 
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In South Africa, recent studies suggest that THM is used to manage the symptoms of 
HBP. For instance, a study conducted by Hughes et al. (2013) in Langa, Cape Town, 
found that 51% of their study sample used THM for HBP. Forty eight percent (48%) 
used THM between one and three times a day over extended periods. There is also 
increased interest in the use of THM for the management of T2DM (Erasto et al., 
2005). The aim of this study was to identify and document medicinal plants used 
to manage HBP and T2DM in Bitterfontein, Matzikama municipal district, Western 
Cape Province, South Africa. Since much of the research conducted in the Western 
Cape Province on HBP and T2DM focuses on the Cape Metropole, are older 
studies and/or are population speciﬁc (Levitt et al., 1999; Idemyor, 2010; Erasmus 
et al., 2012; Bailey et al., 2016), information about the prevalence of both 
conditions varies. The number of people medically diagnosed with one, or both, of 
these conditions therefore had to be ascertained and the utilisation of allopathic 
medicines as well as medicinal plants had to be deduced. The latter was 
subsequently compared with extant literature to gain insight into related scientiﬁc 
research, as well as to establish the plants’ conservation status. 
 
2. Materials and methods 
2.1 Study design and sample size 
A cross sectional descriptive research methodology was used to explore THM use 
and practices. The study was designed to gather data at three diﬀerent levels in  
three progressive phases. First, a semi-structured survey was designed and used to 
gather data on the number of people previously diagnosed by health care providers 
with the target conditions, as well as the frequency of THM use over the previous 
four weeks. A simple random sampling method was used to screen all 
households and select one hundred and twelve (112) eligible participants. 
Eligibility criteria included participants who were above eighteen (18) years of age 
and had previously been medically diagnosed with the target condition(s).2 A blood 
pressure reading higher than 140 over 90 mmHg and a RBG < 7.8 mmol/L in 
participants with previous diagnoses of T2DM were considered acceptable levels for 
participation. These readings were initially done at the clinic and are then regularly 
tested by home based care staﬀ. Participants were also questioned about 
allopathic medicine and THM use. Secondly, in-depth semi-structured interviews 
were conducted with twelve (12) key participants, selected through a non-probability 
“snowball” sampling method (Heckathorn, 2011). The municipal councillor for the 
Bitterfontein ward initially mediated the researchers into the local community, and 
assisted in identifying key participants who were especially knowledgeable about 
THM. These participants included community elders, practising  bossiesdokters  
and  Rastafari  bush  doctors.  These  key participants were also regularly 
consulted by locals about THM to manage HBP and T2DM. The third and ﬁnal 
phase comprised two rounds of plant collection during the spring and summer 
months of 2014 and 2015. 
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2.2 Study area 
Bitterfontein is a small semi-rural village situated in the Matzikama municipal area. 
The village is the northernmost settlement on the border of the Western and 
Northern Cape Provinces and lies three hundred and eighty six (386) kilometres 
from Cape Town. Bitterfontein is surrounded by diﬀerent landscapes, from the 
ﬂowing granite hills of the Knersvlakte to the Hardeveld with its hard, dry soil and 
scattered bushy quartz ﬁelds. According to the 2011 Census, Bitterfontein had a 
population of 986 in an area of 39.90 km2. There are 231 households. The majority 
of the population is “coloured” (91.28%) and most of the inhabitants are Afrikaans 
speaking (97.34%). More than half (50.71%) of the population are female and 
49.29% are male (Statistic South Africa, 2011). Economic activity in the area 
comprises tourism, agriculture and mining. Poverty and high rates of 
unemployment (67%) are often seen as contributing factors in studies of poor 
health and non-communicable diseases such as HBP and T2DM (Matzikama 
Municipality, 2013). The village is serviced by a small satellite clinic. (Fig. 1). 
 
2.3 Data collection 
The ﬁrst round of data collection began with surveys in August 2014 and ended in 
September 2014. The surveys were administered by eight trained ﬁeld workers with 
background training in medical anthropology and ethnobotany. One local 
ﬁeldworker acted as a ﬁeld guide and assistant. Field workers screened all houses in 
Bitterfontein, asking the screening questions: are you above the age of eighteen 
years? have you or anyone in the household been medically diagnosed with HBP 
and or T2DM? If a person answered yes to the above, (s)he was asked whether they 
had used THM and/or allopathic medicines during the previous four weeks. The 
aims and objectives of the study were explained, an information leaﬂet was 
provided and informed consent recorded if the person was willing to participate in 
the study. If a participant did not wish to sign a consent form, verbal consent was 
accepted and audio-recorded. Interviews were conducted in the preferred 
language of the participant (English or Afrikaans). 
 
In the second round of data collection, selected participants were revisited. This 
key group included six bossiesdokters, three Rastafari bush doctors and three 
knowledgeable old people. There was an equal number of male and female 
participants. Written informed consent was again conﬁrmed by each participant 
after the aims and objectives of the study were explained in the participants’ 
preferred language (mostly Afrikaans). The interviews were tape recorded and 
extensive ﬁeld notes and photographs were taken with the consent of the 
participants. The topic schedule for the interviews included probing questions to 
enhance consistency and accuracy in participants’ responses and to compare 
responses. The second round of data collection took place from September 2014 to 
April 2015. 
 
http://repository.uwc.ac.za
6 
 
The third round of research involved plant collection from November to 
December 2014 and March 2015. Because the research site was visited during all 
the seasons, the plants were observed in drought conditions and rainy season. The 
plant collection was undertaken with the assistance of a botanist and all of the key 
participants on diﬀerent occasions. Plants were collected three-fold, numbered 
and dry-pressed in the ﬁeld. Together with plant pressings, the collection team 
noted vernacular plant names, their locality, GPS coordinates, habitat, plant 
distribution when collected, plant parts used, preparation and administration 
methods. Each collected specimen included leaves, stems, ﬂowers and fruits where 
available. For small herbaceous plants, the whole plant was collected. The collected 
specimens were deposited at the Herbarium of the University of the Western Cape 
(UWC) together with collection/ﬁeld notes and a comprehensive reference collection 
with representative specimens. The plant names were updated using Kew's plant 
list http://www.theplantlist.org/(accessed and updated: 28.02.2016). 
 
2.4 Data analyses 
After the surveys were completed, they were checked for quality and completeness. 
Data was analysed using IBM SPSS V.22.0. Standard descriptive measures were 
used to describe the study sample and responses to the questionnaire. Chi-square 
tests were used when making comparisons between two groups. All percentage 
distributions were calculated based on non-missing values. No amendments were 
made for missing data or multiple comparisons. 
 
The in-depth, semi-structured interviews were analysed using a thematic content 
analysis method (Heckathorn, 2011). After the interviews, the derived data 
underwent numerous stages of analysis, initially transcribing the material and then 
checking for coherence and saturation. The material from diﬀerent respondents 
were compared with each other to identify patterns and themes. Segments of data 
were then coded. The emerging themes were linked to sections of data with 
associated codes such as plant practices, method of administration and path of 
knowledge. When no new information arose from the material and when no new 
codes or themes emerged, the authors agreed that saturation had been achieved. 
 
 
http://repository.uwc.ac.za
7 
 
 
 
 
2.5. Ethical approval and considerations 
Ethical approval for this study was obtained from the Senate Ethics Committee, 
University of the Western Cape (Project ethics number: 13/8/3). A plant 
collection permit was acquired from Cape Nature (Permit number: 0028-
AAA008-00221). Informed consent was obtained from each participant. 
Participants were informed of the aims and objectives of this research and 
interviewed in their preferred language (Afrikaans or English). 
 
Before the research began the local Councillors representing the Bitterfontein 
constituency, employees of the Matzikama Municipality and the local community 
participated in a seminar in which a Memorandum of Understanding was agreed 
on and signed, and the community's participation and beneﬁt sharing discussed. It 
was made clear that the study was for research purposes only, and not for product 
development. 
 
3. Results and discussion 
3.1 Socio-demographics of participants 
In the study sample, 34.8% of participants were male and 65.2% were female. The 
majority of participants spoke Afrikaans (98.2%) and most were of the Christian 
denomination (94.6%). Participants’ ages ranged from 19 to 87 years. Forty per 
cent (40.2%) of the participants had primary education, 43.8% secondary 
education, 3.6% tertiary education and 12.5% had no formal education. More than 
half of the sample population (50.9%) relied on state funded grants such as 
pensions (33.93%) and disability grants (16.97%). Only 10.7% held full-time jobs 
and a further 34.8% were unemployed. The remaining cohort were employed part-
time (1.8%) or self-employed (1.8%). The total sample of participants who were 
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employed (14.3%), derived their income from work as farm labourers, keeping and 
selling livestock, informal trade and providing labour for mines in the region. A 
large proportion of participants (59.8%) fell within the R0≤R1999 per month 
income category. None of the participants in this study had medical aid 
insurance. Table 1 speciﬁes the socio-demographic characteristics of participants in 
Bitterfontein. 
 
3.2 Medicinal plants used for HBP and T2DM 
Twenty-four (24) plant species belonging to 15 families were documented for the 
management of HBP and T2DM. The plant species, family, vernacular names (speciﬁc 
to the study area), reported use and part of plant used are presented in Table 2. More 
than half (52.79%) of the study sample reported the active use of THM, i.e. they had 
utilised THM at least once a day for the previous two weeks at the time of interview. 
Non-active users (21.11%) utilised THM at least once a week in the four weeks prior to 
the interviews. Lessertia frutescens was the most commonly reported plant species 
(96.55%) among all THM users in this study. The other plant species were not as 
signiﬁcantly reported, and were often used in concoctions together with L. 
frutescens. The most frequently reported families were Asteraceae (20.8%), 
Lamiaceae (16.67%), Crassulaceae (8.33%) and Aizoaceae (8.33%). The remaining 
(45.54%) were evenly split over eleven families-Fabaceae, Amaryllidaceae, 
Anacardiaceae, Capparaceae, Geraniaceae, Apiaceae, Convolvulaceae, Apocynaceae, 
Rutaceae, Asphodelaceae and Thymelaeaceae. Some of these families have been 
documented and researched for their anti-hypertensive and anti-diabetic potential 
(Sunmonu and Afolayan, 2010; Hughes et  al., 2013; Chethan et al., 2014), suggesting 
their importance for the management of HBP and T2DM. 
 
3.3 Inventory of plant species used for HBP and T2DM 
The claimed therapeutic indications of some of the plants reportedly used to 
manage HBP and T2DM in this study have partially been validated by studies in 
experimental animals, while others have been documented for their medicinal use 
in ethnobotanical studies. L. frutescens for example, is the most frequently used 
plant species in this study, widely utilised in the Western Cape and along the west 
coast of South Africa for the treatment of T2DM (van wyk and Albrecht, 2008; 
Rood, 1994; van wyk and Gericke, 2000; van wyk et al., 1997). L. frutescens has been 
investigated as a possible hypoglycaemic agent for managing T2DM, through 
stimulating glucose uptake in pre-diabetic rats (Chadwick et al., 2007). Because 
of its capacity to normalize insulin levels in diabetic patients, L. frutescens is 
considered to be a promising anti-diabetic agent (Sia, 2004). High levels of pinitol 
in L. frutescens leaves were proposed by Moshe (1998) as a possible explanation 
for the anti-diabetic eﬀect of its extract. Tai et al. (2004) found that L. frutescens 
contained not only pinitol, but also non-protein amino acid L-canavanine, gamma 
aminobutyric acid (GABA) and asparganine. The presence of pinitol in L. 
frutescens leaves was shown in studies to be most probably responsible for the anti-
diabetic eﬀects of plant extracts. It is reportedly eﬃcacious in decreasing blood 
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sugar levels and improves the availability of glucose for metabolic reactions to 
occur (Bates et al., 2000; van wyk and Albrecht, 2008; Van-Wyk et al., 2005; 
Deutschländer et al., 2009). The Gamma-aminobutyric acid (GABA) in L. frutescens 
could be of beneﬁt by lowering HBP (Abe et al., 1995; Dalvi, 2003). 
 
There is always concern regarding the safety of THM. Studies on L. frutescens, 
however, have indicated little to no side eﬀects. 
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In a study conducted on Vervet monkeys, no adverse reactions were reported to 
high dosages of aqueous extracts of L. frutescens (Seier et al., 2002). In South Africa 
a Phase I double-blind, placebo-controlled study on healthy individuals found that 
400 mg of leaf powder capsule twice a day for three months was tolerated without 
adverse eﬀects (Johnson et al., 2007). A preclinical study by Minocha et al. (2011) 
does however indicate that the co-administration of L.frutescens with nevirapine 
could aﬀect the pharmacokinetics of this drug in rats. Wilson et al. (2015) 
reported that in a clinical trial on L. frutescens two participants developed 
tuberculosis while also taking isoniazid preventive therapy (IPT). According to the 
study the THM may have reduced the eﬃcacy of IPT. 
 
Diosma oppositifolia was also frequently used for the management of HBP and/or 
T2DM in this study. This species has been described as a broad-spectrum tonic, 
used in the treatment of intestinal discomfort, kidney problems, occasionally for 
external sprains and ﬂatulence (Nortje, 2011; Philander, 2011). The leaves are 
sometimes infused in brandy or vinegar, and synthesizing tinctures used for 
bruises and sprains ( Philander, 2011). At present, there is no available literature 
on scientiﬁc studies concerning anti-diabetic or antihypertensive properties, nor is 
there any information regarding the toxicity of this plant. 
 
Gnidia deserticola is a member genus of the family Thymelaeaceae, consisting of 
approximately 152 species (Bhandurge et al., 2013). There is no information in the 
literature of Gnidia being used to treat HBP and T2DM, though members of the 
genus are used for a wide array of conditions, ranging from asthma to nightmares, 
to yellow fever (e.g. Borris et al., 1998; Van-Wyk et al., 2005). Some Gnidia species 
have displayed severe irritant properties, leading to death in animals and humans 
owing to the prevalence of toxic coumarins and diterpene esters. Adverse 
symptoms resulting from Gnidia intake include inﬂammation of the larynx, edema 
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of the islands, vomiting, discharge of blood upon desiccation, rapid pulse, moist 
skin, muscular twitching and delirium. These symptoms are followed by convulsion 
and death in 20–25% of cases (Bhandurge et al., 2013). The toxicity of the genus 
raises some concern as it is readily used in plant preparations in Bitterfontein. 
 
Tulbaghia violacea has reportedly  been used  to treat HBP and T2DM, but also 
fevers, inﬂuenza, intestinal worms, oral infections, asthma and tuberculosis (Raji 
et al., 2015; Lyantagaye, 2011; Moodley et al., 2015). T. violacea falls within the same 
family as Allium sativum L., a species utilised as a remedy for T2DM in 
traditional Indian medicine  (Mukherjee  et  al.,  2006).  Other  members  of  the  
family possess similar phytochemical compounds (Cox and Ballick, 1994; Motsei 
et al., 2003), such as T. violacea, which contains sulphur compounds: often 
accounting for the distinguishing odours and the medicinal potential of both the 
Tulbaghia and Allium species (Lyantagaye, 2011). Aqueous extracts of T. violacea 
show substantial glucose uptake in Chang liver cells. T. violacea contains 
phytochemical components such as steroidal saponins, quercetin, kaempherol, 
sugars, and/or sulphur-containing compounds (Duncan  et al., 1999)  which could 
have potential glucose-lowering eﬀects. Similarly, sulphur containing compounds 
in this species have been found to result in hypoglycemic eﬀects in diabetic 
animals, arising from their antioxidant activity (Mukherjee et al., 2006). 
 
Infusions of T. violacea extracts have been found to decrease systolic blood pressure 
(SBP) in male spontaneously hypertensive Wistar rats (SHR) (Raji et al.,2015) and 
in normotensive male Wistar rats (Ramesar et al., 2008), compared to the 
corresponding values in the control rat groups in experiments. A study by 
Lyantagaye (2011) examined the eﬀects of T. violacea methanolic extract on blood 
glucose, serum lipids and anti-oxidative status in streptozotocin induced diabetic 
rats. Plasma insulin levels were found to be signiﬁcantly reduced in the diabetic 
control and treated diabetic groups compared to the non-diabetic control group (p 
< 0.001). T. violacea treatment produced a notable hypoglycemic eﬀect by dropping 
fasting glucose levels and cultivating glucose tolerance. The antioxidant activity of 
T. violacea has been attributed to the presence of organo sulphur compounds, 
which are believed to possess powerful antioxidant properties capable of 
stimulating liver antioxidant enzymes (Günthner, 2009). It has been  noted  that  
prolonged  and  excessive use of T. violacea bulbs causes gastrointestinal distress 
and may be related to acute inﬂammation and sloughing oﬀ of intestinal tissue, as 
well as the interruption of peristalsis (Lyantagaye, 2011). Artemisia afra is 
extensively utilised in Southern Africa for the treatment of T2DM, as well as for 
coughs, colds, headaches, loss of appetite, gastric imbalances, colic, gout, asthma, 
malaria, kidney and bladder disorders, inﬂuenza, convulsion, fever, heart 
inﬂammation, rheumatism and as a purgative (Watt and Breyer-Brandwijk, 1962; 
Thring and Weitz, 2006; Patil et al., 2011; Afolayan, 2013; Mukinda et al., 2010; 
Mukina and Syce 2007). Sunmonu and Afolayan (2010) evaluated the antioxidant 
properties of aqueous extract of A. afra leaves on the kidney and liver of rats with 
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streptozotocin-induced diabetes. Its eﬀectiveness was found to be comparable to 
glibenclamide, a standard hypoglycaemic drug. Several of the complications of 
T2DM have been associated with oxidative stress and antioxidants have been 
considered as potential treatments (Reaven et al., 1995; Cunningham, 1998). As 
such, antioxidant action could play a signiﬁcant role in the treatment of diabetes 
through THM with this property. This may be an indication that A. afra extract 
could potentially be a useful therapeutic instrument for treating oxidation-related 
pathological damage (Wongkham et al., 2001). Issa and Bule (2015) found that 
blood glucose levels in Alloxan induced diabetic Swiss albino mice signiﬁcantly 
decreased (by 24%) in groups that were given A.afra doses of 500 mg/Kg and by 
56.9% in groups that received 750 mg/Kg, respectively. The methanolic extract of 
A. afra also lowered blood glucose by 49.8% in doses of 1000 mg/Kg. The same 
study also found that A. afra was non-toxic. Other studies pertaining to the 
bioactivity of A. afra include its potential use as an antifungal agent (Gundidza, 
1993), its antibacterial activity (Rabe and van Staden, 1997), as an antioxidant 
(Burits et al., 2001), its potential toxicity (Elgorashi et al., 2003), and its anti-
cancer (Fouche et al., 2008), anti-tuberculotic (Mativandlela et al., 2008) and 
anti-malarial (Van der Kooy et al., 2008) eﬀects. It has also been studied for its 
protective myocardial uses (Sunmonu, Afolayan, 2010), and its inﬂuence on the 
central nervous system (Nielsen et al., 2004). Guantai and Addae-Mensah (1999) 
found that aqueous A. afra extract (10–45 mg/kg) had a hypotensive eﬀect when 
tested in vivo (Patil et al., 2011). 
 
The pharmacology of Chrysocoma ciliata L. has not been signiﬁcantly studied in 
South Africa. C. ciliate has however been documented in ethnobotancal studies in 
the north west region of South Africa (Nortje, 2011; De Beer and van wyk, 2011) for 
its use for stomach complaints, colds and pain. Afolayan et al. (2009) studied the 
anti-fungal activity of C. ciliate. The species exhibited a strong anti-fungal 
propensity in relatively low doses. The plant's possible toxicity has not been 
investigated. 
 
Leonotis leonurus is a widespread species found all over the Cape ﬂoristic region. 
Studies have documented its use and eﬃcacy for both HBP (Kenechukwu, 2004) 
and T2DM (Afolayan and Sunmonu, 2010). Studies have reported on the anti-
diabetic, hypoglycemic, anti-convulsant, anti-nociceptive, anti-inﬂammatory, and 
anthelmintic activities and properties of L. leonurus (Kuete, 2013). Mnonopi et al. 
(2012) tested marrubiin, a constituent of L. leonurus and an organic extract of the 
plant in vitro and in vivo for their antidiabetic propensity and found that it alleviated 
diabetic symptoms. Further studies have also reported on the immune modulatory 
eﬀects of L. leonurus (Hurinanthan, 2009). The main psychoactive component of 
L. leonurus is leonurine. In a medicinal species review, Mazimba (2015) notes that 
the species has 37 isolated phytochemicals consisting of ﬂavanoids, labdane type 
diterpenoids and other phenolics detected in acetone and methanol extracts. The 
essential oils of L. leonurus were also shown to have anti-oxidant and anti-bacterial 
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properties. Studies have been done on the plant's toxicology in rats (Kuete, 2014). 
It showed possible adverse eﬀects on organs, red blood cells and white blood cells 
(Maphosa et al., 2008). 
 
Although no studies have been done on the anti-diabetic potential of Tagetes 
minuta it is reported as a “traditional” medicine. Its leaves and stem are used to 
make a decoction for pain, inﬂammation, and as a blood puriﬁer in the case of 
T2DM. A study conducted by Al-Musayeib et al. (2014) documented T. minuta's 
anti–oxidative and anti–inﬂammatory eﬀects. A phytochemical investigation of 
the methanolic extract of T. minuta leaves resulted in the isolation and 
identiﬁcation of new compounds:  5-methyl-2,2',5',2'',5'',2′'',5′'',2''''-
quinquethiophene  (1) and quercetagetin-6-O-(6-Ocaﬀeoyl-β-D-glucopyranoside)- 
(9) (Karimiana et al., 2014). While T. minuta is widely used and considered to be 
safe, its oil and extracts can cause photo-toxicity (Scientiﬁc Committee on 
Consumer Safety, 2015). 
 
Hoodia gordonii is native to the Kalahari desert in southern Africa (van Heerden, 
2008). The species has received a lot of media and scientiﬁc scrutiny as an 
appetite suppressant and dietary supplement, but not for the management of HBP 
or T2DM. The active ingredient in H. gordonii is the appetite-suppressing molecule, 
P57, or oxypregnane steroidal glycoside P57AS3.3 (Madgula et al., 2008). In clinical 
studies, P57 has been evaluated for its potential as an anti-obesity drug. It is 
argued that P57 mimics the action of glucose on the brain. Clinical studies have 
found that H. gordonii is non-toxic (Maharajah, 2001), although side eﬀects of H. 
gordonii based products have been reported. In a study conducted by Roza et al. 
(2013), an H. gordonii product was tested for sympathomimetic activity. Through 
isolated organ experiments on rat uterine rings, the product was found to have 
smooth muscle relaxant eﬀects with a substantial component mediated through β-
adrenergic receptors. It was also argued that cardiovascular eﬀects of the product 
may be linked to the H. gordonii compounds. Studies have associated the 
administration of H. gordonii extract with an increase in blood pressure and pulse 
rate. 
 
Aloe ferox has traditionally been used for cuts, sores and burns. It is also a strong 
laxative and blood puriﬁer. Much of the clinical data available for A. ferox is based 
on other studies done on Aloe vera and Aloe arborescens species. Loots et al. (2011) 
for example conducted a study to investigate the possible anti-diabetic eﬀects of 
ethanol extracts of A. ferox and A. greatheadii var. davyana leaf gel in a 
streptozotocin (STZ)-induced T2DM rat model. It was found that supplementation 
with the species A. greatheadii and A. ferox moderately increased serum insulin  
with  minor corrections in  ALP  and HDL-C and no change to end-point plasma 
glucose values which resulted in a clinically relevant improved diabetic state, 
suggesting that these Aloe species may show promise for managing T2DM. The 
literature does not refer to it as possible treatment for HBP per se although A. ferox 
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leaf gel has promise for the prevention or alleviation of symptoms associated with 
cardiovascular diseases (Du et al., 2007). A. ferox has a laxative eﬀect but is safe for 
human use (Celestino et al., 2013; Mahomoodally, 2013). 
 
At present, there is little information available on the anti-diabetic and 
antihypertensive activity of Convolvulus capensis Burm. f., Pelargonium 
antidysentericum (Eckl. & Zeyh.), Carpobrotus edulis (L.) L. Bolus, Salvia 
africana-caerulea L, Mentha longifolia L., Euryops abrotanifolius (L.) DC., Ballota 
Africana (L.) Benth, Tylecodon paniculatus (L.f.) Toelken and Crassula muscosa 
(Linnaeus, 1760) and Searsia burchellii (Sond. ex Engl.) Moﬀett reportedly used in 
this study. Many of these species have however been documented in 
ethnobotanical surveys for their use against HBP and T2DM (Nortje, 2011; Mintsa 
Mi Nzue, 2009; van wyk and Albrecht, 2008; Arendse, 2013; Philander, 2011). They 
are also widely used as tonics for stomach complaints, colds, fever, rheumatism 
and many other illnesses. In literature some have been mentioned anecdotally for 
their traditional uses. For example, Cadaba aphylla (Thunb.) Wild has been 
documented for its anti-cancer activity (Fouche et al., 2008) and Dicerothamnus 
rhinocerotis (L.f.) Koek., for its anti-carcinogenic activity (Dwarka, 2012). 
Lichtensteinia lacera Cham. & Schltdl. has been listed as a plant frequently used for 
T2DM, but there is no scientiﬁc endorsement of its safety or eﬃcacy (Patil et al., 
2012). Sceletium tortuosum (L.) N.E. Br. has been documented for its use in 
managing T2DM (Semenya and Potgieter, 2014), and for HIV and TB in the Eastern 
Cape, South Africa (Lawal et al., 2014) This species has also traditionally been used 
to treat chest complaints, colds, fevers and coughing (Philander, 2011). The plant 
has been found to be safe in a clinical trial (Nell et al., 2013). 
 
3.4. Diagnoses 
In the study sample, sixty ﬁve (65) participants had previously been medically 
diagnosed with HBP, 27 with T2DM and 20 were simultaneously diagnosed as 
diabetic hypertensive. All of  these  participants were diagnosed by health  care  
professionals  at  the  Bitterfontein satellite clinic, prior to being interviewed. Blood 
pressure  and  blood sugar are regularly tested and monitored by clinic and home-
based care staﬀ. Similar studies conducted in the Western Cape Province have also 
reported high occurrence of HBP (Lloyd-Sherlock et al., 2014b), and in T2DM, 
prevalence's of between 4.4% and 9.4% respectively (Erasmus et al., 2012; Bailey et 
al., 2016). 
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The reported prevalence of HBP (8.62%) and especially T2DM in this study 
(4.77%) is comparable. In the Bitterfontein study, 70.4% of participants with 
either, or both, conditions are over 40 years of age. Studies have shown that age is 
a risk factor for HBP and T2DM (Ibid.). Although access to diagnoses, treatment 
and management of both conditions are generally good in South Africa, a 
systematic review showed that less than 10% of T2DM suﬀerers still do not have 
access to diagnoses and treatment (Health24, 2014). Between 12.7% (Erasmus et al., 
2012) and 18.1% (Bailey et al., 2016) were undiagnosed. A large proportion of 
diagnosed participants in prevalence studies do not manage their conditions with 
allopathic medicine or refuse to do so (Erasmus et al., 2012; Hughes et al., 2013; 
Bailey et al., 2016). This may result in the search for alternative therapies and 
diagnoses, which is often the case in South Africa. 
 
Diagnosed participants generally collected, prepared and consumed plant remedies 
on their own, or obtained it from knowledgeable elderly family members, neighbours, 
bossiesdokters or Rastafari bush doctors. They used it for general well-being and to 
manage symptoms of HBP such as feelings of heat/ﬂushing or sweating, headache, 
sleeplessness, anxiety and occasional nosebleeds, and for T2DM symptoms such as 
tiredness, frequent urination, increased hunger and/or thirst, weight loss, dark 
patches on the skin, blurred vision and lesions that did not heal easily. Plant 
remedies were also consumed to combat side-eﬀects from their prescribed 
allopathic medication. These included headaches, dizziness, nausea, stomach pain, 
tingling in ﬁngers and toes and erratic heart rate. Participants displayed a good 
understanding of the symptoms of HBP and T2DM based on responses to a range of 
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possible symptoms presented to them in the survey questionnaire. Much of the 
understanding of their conditions is drawn from public information available from 
the clinic, library and media (radio, television, magazines). Experienced symptoms are 
explained to them by health care staﬀ. 
 
Since both HBP and T2DM are considered to be linked to lifestyle (poor nutrition, excess 
salt or sugar, hard labour, stress, etc.) and genetic factors, participants regarded these 
conditions as natural and did not consult bossiesdokters or Rastafari bush doctors for 
diagnosis. Instead, bossiesdokters and Rastafari bush doctors were consulted for their 
specialist knowledge of medicinal plants to use for these (already diagnosed 
conditions) or for speciﬁc and/or persistent symptoms. Although bossiesdokters and 
Rastafarian bush doctors treated and recommended plant remedies for HBP and 
T2DM, they generally relied on the information given by a client about a medical 
diagnosis, or attended to the symptoms a client presented with, before providing a 
plant remedy. The use of plant remedies, their dosage, mode of administration and 
duration of use was thus found to be aimed at and dependent on the presence and 
severity of symptoms. 
 
3.5 Preparation and administration 
The preparation and administration of each mixture depends on the severity  and  
duration  of  symptoms.  Plants  are  collected  from  the commons of Bitterfontein, 
provided by the elderly or bossiesdokters or bought from Rastafari bush doctors. 
Sometimes plants are purchased from Rastafari bush doctors in bigger town 
centres. Here plants are displayed and sold as part of an informal market in 
THM. In cases where a speciﬁc plant is neither available in the area nor present in 
the veld,3 participants travel  to  neighbouring areas  to collect them,  or order 
them from bossiesdokters and Rastafari bush doctors who occasionally travel to 
other areas to collect them. Some of the plants used, such as Tagetes minuta, have 
been naturalised and often grow in gardens. Elderly participants, who are unable to 
walk to the veld, often cultivate medicinal plants in their gardens for ease of 
access. Participants generally preferred to collect plants in the wild, in the spring 
and summer months when they were more readily available. These seasons are 
also considered to yield strong plants with high potency. 
 
Plant mixtures varied from one participant to the next as did the use of fresh and 
dried plant material. When fresh plant material was available, it was generally ﬁrst 
dried, as such plants were believed to be stronger. Plants collected from the veld are 
generally considered more potent and the plant species were mostly used in 
combinations. Participants did not make a distinction between plants used to 
treat HBP and T2DM individually. Instead, plant preparations contained up to ﬁve 
plants to address the symptoms of both conditions. Many of the reported 
preparations included L. frutescens. In some instances, plants were added to 
combat diﬀerent symptoms or to make a more potent decoction which would 
possibly work faster. Plants were also added to a mixture to mediate the side-
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eﬀects of another plant, e.g. G. deserticola, to improve taste and/or as a general 
tonic. The traditional practice of using multiple plants in a combined decoction 
has been documented in other studies (Alarcon-Aguilara et al., 1998; Davids et al., 
2014; Hughes et al., 2014; Hughes et al., 2015). There is evidence to suggest that the 
use of multiple plants decreases the probability of resistance to it for a singular 
condition. In this study, participants explained that multiple plants were used 
because they complemented one another. 
 
Most of the plant preparations were taken orally, usually prepared as decoctions or 
infusions. In addition, mixtures were sometimes used for bathing or for inhalation. 
Topical application of plants were used to treat rashes and sores which took long to 
heal, especially as a result of T2 DM. The duration of treatment lasted until 
symptoms or side-eﬀects cleared up, generally within two weeks, at which time the 
strongest infusions were consumed one to three times a day. Thereafter, 
preparations were consumed less frequently. 
 
3.6 Part of plant used 
The leaves (57.63%) were the most frequently used plant part in preparations for 
the management of HBP and T2DM. Other plant parts (Fig. 2) were also utilised, but 
to a lesser extent. The widespread use of leaves in medicinal preparations is well 
documented in ethnobotanical studies (Hughes et al., 2013; Davids et al., 2014; 
Hughes. et al., 2015). The traditional belief that leaves are the strongest part of the 
plant, oﬀering the most potency in relation to other parts, has encouraged their 
extensive use. It also raises potential concerns about over-use and conservation 
(Loundou, 2008; Mintsa Mi Nzue, 2009; Street and Prinsloo, 2013). 
 
3.7 Allopathic medication and THM co-utilisation 
In this study, 48.21% of diagnosed participants used only allopathic medication for 
HBP and T2DM. A further 20.11% of this group had reportedly used THM in the 
previous four weeks (non-active use). Approximately one third of participants 
(34.82%) who had previously been  diagnosed  with  HBP  and/  or  T2DM  used  
THM  along  with prescribed allopathic medication, although not simultaneously. 
While minimal reports (11.6%) of minor side eﬀects such as nausea and 
headaches from using both were reported, participants took caution to consume 
THM at diﬀerent intervals from their prescribed allopathic medication. They 
argued that this prevented any potential eﬀects of the plants on the drugs. Similar 
ﬁndings have been reported in other studies. Hughes et al. (2013) found that THM 
was frequently used together with allopathic medication amongst hypertensives 
living in South African communities. Liwa et al. (2014) found that 47.5% of HBP 
suﬀerers in sub-Saharan Africa use allopathic medication together with THM. 
Davids et al. (2014) showed that traditional health practitioners from Strand, 
Western Cape readily treat HIV and related opportunistic infections with medicinal 
plant preparations, while patients are on antiretroviral therapy. Hughes et al. 
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(2015) found that HIV positive patients used THM in conjunction with allopathic 
medication, with no reported side-eﬀects. 
 
At present, allopathic medication as a single or in multi-drug therapies cannot 
return blood glucose levels to normal or maintain blood pressure and there are 
many  reported  side-eﬀects of  its  use (Chethan et al., 2014). Plants are therefore a 
potentially useful source of complementary supplements for maintaining blood 
pressure, blood glucose levels and preventing chronic complications in T2DM 
(Gallagher et al., 2003). In this regard, recent studies have investigated the 
synergistic use of plant products in combination with allopathic medication. For 
example, Aiyegoro and Okoh (2009) conducted research on the bio-microbial 
activity of plant products in combination with allopathic medication against anti-
microbial chemotherapy and they argue that plant products can potentially act as 
synergistic enhancers when used in combination with allopathic medication. 
Sibanda and Okoh (2008) investigated the interactions between acetone extracts 
of Garcinia kola seeds and antibiotics. Oliveira et al. (2015) found that there was a 
possibility of interaction when using medicinal herbs and allopathic medication 
together. 
 
Despite its occurrence, concurrent use of THM and allopathic medication has not 
received much scientiﬁc scrutiny (Amira and Okubadejo, 2007; Olisa and Oyelola, 
2009; Hughes et al., 2015). In part, the concurrent use of allopathic medication 
and THM is attributed to the limitations of allopathic medication, shortages of 
health care service providers (Steyn et al., 2008), insuﬃcient access to allopathic 
medication, patient perceptions about allopathic medication and how it interacts 
with bodily processes (Cohen, 2009), and the adverse side-eﬀects of some 
allopathic medications. Plant preparations are generally believed to be eﬀective 
with fewer side-eﬀects (Erasto, 2005). In this study, 16.97% of diagnosed 
participants used only THM, to manage HBP and T2DM. Health care practitioners, 
service providers and users alike should be made aware of the possible implications 
for using THM as the sole form of therapy. 
 
3.8.  Conservation 
In South Africa, numerous biodiversity and conservation strategies, organizations 
such as Cape Nature, the Plant Conservation Alliance (PCS), the Global strategy for 
plant conservation (GSPC) and the South African National Biodiversity Institute's 
Red List of plants, are in place to protect, preserve and monitor vulnerable plant 
groups. A national strategy for plant conservation is also being developed (Ralston 
et al., 2009; SANBI, 2014; Victor et al., 2015). Mountainous habitats and nature 
reserves are generally well conserved in South Africa, but lowland regions and 
especially the Renosterveld area is prone to biodiversity pressures such as ﬁre, 
agriculture, invasive alien species, pollution, urbanization and climate change 
(Kemper et al., 1999; Von Staden et al., 2013). In relation to medicinal plants, 
several studies in South Africa have shown the impact of over-harvesting in the 
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trade of such plants (Cocks and Dold, 2004; Cunningham, 2003; Mander et al., 
2007; Street et al., 2008; Loundou, 2008; Moeng and Potgieter, 2011). Many 
medicinal plants are threatened and some are extinct (Street et al., 2008). 
 
The extensive use (35.59%) of roots/bulbs, stems and the whole plant (Fig. 2) in 
this study pose a potential future risk for conservation of some plant species used 
in the management of HBP and T2DM. Most of the plant species reported in 
Bitterfontein (87.5%) have been evaluated by the South African National 
Biodiversity Institute's (SANBI, 2015) threatened species programme (Red data list) 
and were categorized as ‘least concern’. This category includes species which have 
been evaluated against international conservation standards. The focus of the red 
list is on monitoring species which are at high risk of extinction and as a result the 
species categorized as of least concern, may still be of high conservation concern. 
The species Chrysocoma ciliate and Tagetes minuta (8.33%) were not assessed 
according to Red list criteria because they are not indigenous, but can be 
considered “naturalised exotics.” Hoodia gordonii (4.17%) was also not evaluated 
due to insuﬃcient data. Although H. gordonii is widespread throughout the Cape 
Floristic Region, the species has undergone a rapid decline as a result of 
overharvesting. 
 
The low reported prevalence of some of the plant species in this study may be an 
indication of its scarcity. Biodiversity and conservation strategies are an important 
tool for monitoring threatened species and should be advocated in rural areas. The 
use of plants as medicine is a long-standing practice in areas such as Bitterfontein 
and is part of the health and well-being of THM users. The sustainable 
conservation of plants, especially medicinal plant species, is important not only 
because of their value as a potential source of new medicine, but also to conserve 
species for future use. 
 
The harvesting of plants is closely monitored by Cape Nature in the Western Cape. In 
Bitterfontein participants employ a range of practices centered on minimal use and 
sensitivity to plant harvesting. Similar studies conducted in the Western Cape 
(Olivier, 2012; Philander, 2011, 2014) and Northern Cape (Cohen, 2009, 2013; 
Nortje, 2011) have shown that most of the plants harvested, used and sold by 
bossiesdokters and Rastafari bush doctors are not endangered.  Furthermore, these 
studies have shown that bossiesdokters (Cohen, 2013) and Rastafari bush doctors 
(Olivier, 2012) have a good sense of awareness of plant conservation. Overall, 
participants in this study reportedly only collected plant material as they needed it, 
and in moderate quantities. Most THM users did not harvest plants for sale, nor did 
they store large quantities of plant material for future use. When collecting 
plants, participants harvested samples from multiple mature specimens and did 
not harvest young plants. Although participants collected from Bitterfontein 
commons, they also varied their collection locations from time to time. They were 
careful not to disturb the growth of the plant by uprooting it except when the roots 
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and bulbs were needed for speciﬁc remedies and symptoms. Speciﬁc species, which 
are known to be scarce, were often substituted with other species which are believed 
to possess similar properties. The predominant use of leaves (57.63%) and of 
multiple plant species for the same application also suggests these as possible 
conservation strategies by locals to prevent over-harvesting of speciﬁc species and 
to safeguard its future use. 
 
4. Conclusions 
Twenty-four plant species belonging to 15 families were identiﬁed and documented 
for the management of HBP and T2DM. Lessertia frutescens was the most 
frequently reported plant species among all THM users in this study. This is 
suggestive of its importance as ethnomedicine for the management of HBP and 
T2DM in Bitterfontein. Medicinal plant concoctions contained up to ﬁve plant 
species mostly prepared as infusions and decoctions for oral administration. 
 
Although, HBP and T2DM suﬀerers consulted and received treatment from 
bossiesdoktors and  Rastafari bush doctors,  they always relied  on  biomedical  
diagnoses  before  managing  the  symptoms  of either condition with THM. 
Medicinal plants are widely used by HBP and T2DM suﬀerers who employ diverse 
plant species to manage the symptoms of both conditions. Plant collectors employ a 
range of plant conservation methods to ensure its future use. Although suﬀerers 
displayed a good understanding of the symptoms of, and biomedical treatment 
regime for HBP and T2DM, a large proportion of THM users in this study 
reportedly used their prescribed allopathic medication together with medicinal 
plants. They reported minor side-eﬀects. The potential interaction of some of the 
plant species used with allopathic medication has not received much scientiﬁc 
scrutiny in the past. Health care providers could be sensitized to the pluralistic 
treatment choices of HBP and T2DM suﬀerers and to the possibility of herb-drug 
interaction. Nevertheless, the use of THM continues to be a potential source of new 
and alternative strategies to manage chronic conditions such as HBP and T2DM. 
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